[The antimyorelaxant effect of cholinopotentiating drugs].
D000549:Ambenonium Chloride / Q000494:pharmacology*; D000818:Animals; D001001:Anura; D002800:Cholinesterase Inhibitors; D003124:Colorimetry; D005702:Galantamine / Q000494:pharmacology*; D008297:Male; D008916:Miotics / Q000494:pharmacology*; D009388:Neostigmine / Q000494:pharmacology*; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D063065:Organophosphonates / Q000494:pharmacology*; D010710:Phosphates / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*; D051381:Rats; D014403:Tubocurarine / Q000037:antagonists & inhibitors*
D002800:Cholinesterase Inhibitors; D008916:Miotics; D003473:Neuromuscular Nondepolarizing Agents; D063065:Organophosphonates; D010710:Phosphates; D005702:Galantamine; D009388:Neostigmine; D000549:Ambenonium Chloride; D010830:Physostigmine; D014403:Tubocurarine
Izuchenie antimiorelaksantnogo éffekta kholinopotentsiruiushchikh sredstv.